Open AccessThe Utility of Xenon-133 Liver Scan in the Diagnosis and Management of Nonalcoholic Fatty Liver Disease
Author(s) -
Said A. AlBusafi,
Peter Ghali,
Philip Wong,
Javier A. Novales-Diaz,
Marc Deschênes
Publication year - 2012
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2012/796313
Subject(s) - nonalcoholic fatty liver disease , medicine , liver biopsy , fatty liver , steatosis , population , chronic liver disease , gastroenterology , liver disease , radiology , biopsy , disease , cirrhosis , environmental health
Nonalcoholic fatty liver disease (NAFLD) is an important and common condition affecting approximately 20% of the general population. Given the limitation of radiological investigations, diagnosis often requires a liver biopsy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom